Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults (Discovery)
2026年7月2日 更新者：Abdelaziz Alsharawy、The University of Texas Health Science Center, Houston
Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults
This study seeks to:
- Identify behavioral preference patterns that characterize older adults vulnerable to financial exploitation.
- Estimate the extent to which biases in decision-making process influence financial decisions among older adults vulnerable to financial exploitation to refine information content and behavioral 'nudge' strategies.
調査の概要
状態
まだ募集していません
研究の種類
観察的
入学 (推定)
400
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究連絡先
- 名前：Abdelaziz Alsharawy, PhD
- 電話番号：(713) 500-9000
- メール：Abdelaziz.Alsharawy@uth.tmc.edu
研究場所
-
-
Texas
-
Houston、Texas、アメリカ、77030
- The University of Texas Health Science Center at Houston
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
はい
サンプリング方法
非確率サンプル
調査対象母集団
For online-only participation, 200 older adults (OAs) recruited via Prolific, a crowdsourcing platform.
Those participating in-lab at the Health Decision Science Lab will include 200 OAs recruited from the Houston area (that is, participants who signed up to the study team's SONA system database).
説明
Inclusion Criteria:
- Adults over the age of 60
- English speakers, to ensure comprehension of study tasks
Exclusion Criteria:
- Less than age 60
- Non-English speaker
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Older Adults who are less vulnerable to financial exploitation
Vulnerability to financial exploitation will be assessed via the Financial Exploitation Vulnerability Scale (FEVS) assessment.
|
|
Older Adults who are more vulnerable to financial exploitation
Vulnerability to financial exploitation will be assessed via the Financial Exploitation Vulnerability Scale (FEVS) assessment.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Frequency of choosing the riskier option on the risk tolerance decision-making task
時間枠：During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize risk tolerance (willingness to accept uncertain outcomes).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more trusting option on the trust decision-making task
時間枠：During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize interpersonal trust (willingness to accept being vulnerable to other people).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more altruistic option on the altruism decision-making task
時間枠：During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize altruism (willingness to incur a financial cost to benefit another person).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more patient option on the impatience decision-making task
時間枠：During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize patience (willingness to forego a sooner reward for a bigger future reward).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the less loss-averse option on the loss-aversion decision-making task
時間枠：During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize loss aversion (tendency to weigh potential losses more heavily than equivalent gains).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Physiological arousal as measured via heart rate
時間枠：During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Physiological arousal as measured via skin conductance
時間枠：During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Physiological arousal as measured via pupil dilation
時間枠：During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Frequency of facial expressions associated with valence and engagement
時間枠：During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
Facial expressions will be assessed using a facial expression analysis system (iMotions software).
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Attention as assessed by eye fixations
時間枠：During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
Relative fixation duration on each option in the behavioral tasks will be measured via an eye tracker (SmartEye).
|
During the time of the decision-making tasks (about 20-40 minutes)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Response time during the behavioral tasks
時間枠：During the time of the decision-making tasks (about 20-40 minutes)
|
Response time will be reported as the time from stimulus presentation to choice, in milliseconds.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
捜査官
- 主任研究者：Abdelaziz Alsharawy, PhD、The University of Texas Health Science Center, Houston
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (推定)
2026年8月1日
一次修了 (推定)
2027年12月1日
研究の完了 (推定)
2027年12月1日
試験登録日
最初に提出
2026年6月26日
QC基準を満たした最初の提出物
2026年6月26日
最初の投稿 (実際)
2026年7月6日
学習記録の更新
投稿された最後の更新 (実際)
2026年7月7日
QC基準を満たした最後の更新が送信されました
2026年7月2日
最終確認日
2026年7月1日
詳しくは
本研究に関する用語
その他の研究ID番号
- HSC-SPH-25-0344 (Discovery)
- P30AG086563 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
いいえ
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。